1 Min Read
April 11 (Reuters) - GlaxoSmithKline Plc:
* Change to financial reporting framework
* As a result of its latest review, GSK will be making following change to its financial reporting from Q1 2017.
* Core results will be renamed adjusted results and will include 'ordinary course' legal charges
* From Q1 2017, only significant legal charges and expenses will be excluded in order to present adjusted results.
* Change is not expected to affect group's previously announced guidance for 2017 or group's outlook for five-year period 2016-2020
* Target expectation of at least 6 bln stg of revenue/ year on a CER basis by 2020 from products launched since 2013 is now expected to be met up to 2 yrs earlier
* Expects volume demand for its products to increase, particularly in emerging markets Source text for Eikon: Further company coverage: (Bengaluru Newsroom)